IRF8 and Alzheimer disease: In our study, IRF8 was significantly downregulated in response to Hyb87 vs PBS (FDR‐adjusted P = 2.6E‐5 and log2 fold change = −0.54 for IRF8), indicating that Hyb87 could reverse the IRF8 signature in human AD microglia.